Inimmune to Play a Key Role at the World Vaccine Congress on April 3-6, 2023
MISSOULA, Mont., March 29, 2023 /PRNewswire/ — Inimmune, a leading biotech company focused on the development of novel vaccine adjuvants, immunotherapies and delivery systems, announced today that its Chief Scientific and Strategy Officer, Jay Evans, Ph.D., and its Chief Operating Officer, David Burkhart, Ph.D., will play key roles at the World Vaccine Congress event.
Inimmune Co-Founder and Chief Scientific and Strategy Officer, Dr. Jay Evans, will be a featured panelist at the 2023 MT Economic Outlook Seminar
Inimmune Co-Founder and Chief Scientific and Strategy Officer, Dr. Jay Evans, will be a featured panelist at the 2023 MT Economic Outlook Seminar, “The Future of Montana: What the New Wave of In-Migration Means for the State”, on January 27th at the Hilton Garden Inn (Missoula). Please visit 2023 MT Economic Outlook Seminar for more […]
Vaccine Adjuvants
Vaccines are one of the most successful medical interventions in human history, saving 2.5 million lives per year and protecting millions more from severe illness and hospitalization, according to the WHO. Despite this incredible success, there are many infectious diseases for which effective vaccines do not currently exist. One strategy to developing new or more […]
Bioscience research and development can unlock the economic potential of the Mountain West
Bioscience research and development can unlock the economic potential of the Mountain West, providing jobs and substantial economic benefit. Read how Inimmune Corporation in Missoula, Montana is bridging academic research and commercial development with the Center for Translational Medicine at the University of Montana.
Science Behind the Silent Killer
To passing eyes, the town of Puyallup where Tomi Cook spent her high school years looks the perfect picture of Seattle suburbia. Quiet cookie-cutter houses, rows of shopping centers, happy upper-middle-class families going about their happy lives. She doubts anyone would have suspected that pills were tearing through her community. For Cook it started with […]
Development of COVID-19 Vaccine, Tests Advancing in Montana
Inimmune Corporation is joining in on efforts to develop a COVID-19 vaccine with a nasal spray that could offer protection against coronavirus. The research efforts are in collaboration with the University of Montana’s Center for Translational Medicine and Rocky Mountain Laboratories in Hamilton.
Montana Biotech Company Receives $2 M Small Business Innovation Research Grant to Advance Vaccine Technologies
Inimmune Corporation, a biotechnology company located in Missoula, MT, was recently awarded a $2 M grant from the National Institute for Allergy and Infectious Diseases (NIAID) under its Small Business Innovation Research (SBIR) Direct to Phase II program to advance a novel adjuvant and delivery system for vaccines. Adjuvants are vaccine components that stimulate and […]
Biotech Company Announces $22 Million Investment Led by Mike Goguen’s Firm
Inimmune, a Missoula-based biotech company founded by nationally recognized vaccine scientists that has been working on a vaccine for COVID-19, announced today that it has raised $22 million in Series A funding led by Two Bear Capital, a venture-capital firm founded by Whitefish philanthropist Mike Goguen. The firm plans to use the Series A investment […]
Inimmune raises $22 Million in Series A Funding Led by Two Bear Capital
(Missoula, MT) Inimmune, www.inimmune.com, a biotechnology company developing immune therapies and components for more effective vaccines, announced today that it raised $22 million in Series A funding. It was the Missoula-based company’s first outside investment. The round was led by Two Bear Capital, www.twobearcapital.com, a new firm based in Whitefish, Montana. Two Bear Capital Founder and Managing Partner Michael […]
UM Receives Largest Single Research Award in its History
MISSOULA – The National Institutes of Health has awarded the University of Montana a five-year, $33.4 million award for the development and clinical trials of opioid vaccines. It is the largest such award in University history. The award was funded through the NIH HEAL Initiative, a national effort to speed scientific solutions to the national opioid […]